|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
Veterinary medicine
|
|
Package code:
|
1792537
|
|
Name of medicinal product:
|
Arti-Cell Forte
|
|
Active substances:
|
chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells
Estonian,
English,
Latin
|
|
ATC code:
|
QM09AX80
|
|
Dosage form:
|
suspension for injection
|
|
Route of administration:
|
intraarticular use
|
|
Strengh:
|
1annus 2ml
|
|
Amount in package:
|
2ml 1TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses.
|
|
Safety features:
|
No
|
|
Summary of product characteristics (SPC):
|
|
|
Package information leaflet (PIL):
|
EST
|
|
Labelling:
|
|
|
Withdrawal time:
|
|
|
Species:
|
hobune
|
|
Last imported to Estonia:
|
Never imported to Estonia
|
|
Marketing authorization holder:
|
Boehringer Ingelheim Vetmedica GmbH
|
|
Marketing authorization number:
|
EU/2/18/228
|
|
Marketing authorization issued on:
|
April 2, 2019
|
|
Marketing authorization expires on:
|
April 2, 2024
|
|
Marketing authorization procedure type:
|
Centralised
|
Entry/Changing date:
September 6, 2021
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere